Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.

Lefaucheur C, Gosset C, Rabant M, Viglietti D, Verine J, Aubert O, Louis K, Glotz D, Legendre C, Duong Van Huyen JP, Loupy A.

Am J Transplant. 2018 Feb;18(2):377-390. doi: 10.1111/ajt.14565. Epub 2017 Nov 21.

2.

The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.

Nankivell BJ, Shingde M, Keung KL, Fung CL, Borrows RJ, O'Connell PJ, Chapman JR.

Am J Transplant. 2018 Feb;18(2):364-376. doi: 10.1111/ajt.14609. Epub 2018 Jan 3.

3.

Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.

Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.

Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26.

PMID:
28554738
4.

Cell mediated rejection revisited: Past, current, and future directions.

Hara S.

Nephrology (Carlton). 2018 Jul;23 Suppl 2:45-51. doi: 10.1111/nep.13283. Review.

PMID:
29968416
5.

BK Virus Nephropathy: Histological Evolution by Sequential Pathology.

Nankivell BJ, Renthawa J, Sharma RN, Kable K, O'Connell PJ, Chapman JR.

Am J Transplant. 2017 Aug;17(8):2065-2077. doi: 10.1111/ajt.14292. Epub 2017 May 5.

6.

Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?

Nankivell BJ, P'Ng CH, Chapman JR.

Am J Transplant. 2019 Jan;19(1):132-144. doi: 10.1111/ajt.14888. Epub 2018 Jun 15.

PMID:
29687946
7.

Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.

Zachariah MS, Dwivedi AK, Yip CS, Chang SS, Gundroo A, Venuto RC, Tomaszewski J, Patel SK, Sharma R.

Exp Clin Transplant. 2018 Aug;16(4):391-400. doi: 10.6002/ect.2016.0323. Epub 2017 Dec 5.

8.

Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.

Alkadi MM, Kim J, Aull MJ, Schwartz JE, Lee JR, Watkins A, Lee JB, Dadhania DM, Seshan SV, Serur D, Kapur S, Suthanthiran M, Hartono C, Muthukumar T.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13117.

PMID:
28921709
9.

Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.

Heilman RL, Khamash HA, Smith ML, Chakkera HA, Moss AA, Reddy KS.

Clin Transplant. 2013 Sep-Oct;27(5):772-80. doi: 10.1111/ctr.12201. Epub 2013 Aug 8.

PMID:
23924146
10.

Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.

Shimizu T, Toma H, Hayakawa N, Shibahara R, Ishiyama R, Hayashida A, Fujimori D, Tsunoyama K, Ikezawa E, Kitajima S, Iida S, Ishida H, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2016 Jul;21 Suppl 1:26-30. doi: 10.1111/nep.12766.

PMID:
26972969
11.

Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.

Wiebe C, Gareau AJ, Pochinco D, Gibson IW, Ho J, Birk PE, Blydt-Hansen T, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.

Am J Transplant. 2017 Mar;17(3):703-711. doi: 10.1111/ajt.14015. Epub 2016 Oct 3.

12.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

13.

Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.

Modena BD, Kurian SM, Gaber LW, Waalen J, Su AI, Gelbart T, Mondala TS, Head SR, Papp S, Heilman R, Friedewald JJ, Flechner SM, Marsh CL, Sung RS, Shidban H, Chan L, Abecassis MM, Salomon DR.

Am J Transplant. 2016 Jul;16(7):1982-98. doi: 10.1111/ajt.13728. Epub 2016 Mar 15.

14.

Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury.

Stegall MD, Cornell LD, Park WD, Smith BH, Cosio FG.

Am J Transplant. 2018 Jan;18(1):180-188. doi: 10.1111/ajt.14431. Epub 2017 Aug 18.

15.

Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.

Zhao X, Huang G, Randhawa S, Zeng G, Lunz J, Randhawa P.

Transplantation. 2017 Feb;101(2):395-401. doi: 10.1097/TP.0000000000001118.

PMID:
26901079
16.

Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.

Loupy A, Vernerey D, Tinel C, Aubert O, Duong van Huyen JP, Rabant M, Verine J, Nochy D, Empana JP, Martinez F, Glotz D, Jouven X, Legendre C, Lefaucheur C.

J Am Soc Nephrol. 2015 Jul;26(7):1721-31. doi: 10.1681/ASN.2014040399. Epub 2015 Jan 2.

17.

Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection.

Gallan AJ, Chon WJ, Josephson MA, Cunningham PN, Henriksen KJ, Chang A.

Hum Pathol. 2018 Jun;76:47-51. doi: 10.1016/j.humpath.2018.02.016. Epub 2018 Mar 6.

PMID:
29501487
18.

Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.

Sayin B, Canver B, Gurlek Demirci B, Colak T, Ozdemir BH, Haberal M.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):32-36.

19.

Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.

Adams AB, Goldstein J, Garrett C, Zhang R, Patzer RE, Newell KA, Turgeon NA, Chami AS, Guasch A, Kirk AD, Pastan SO, Pearson TC, Larsen CP.

Am J Transplant. 2017 Nov;17(11):2922-2936. doi: 10.1111/ajt.14353. Epub 2017 Jul 3.

20.

Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants.

Halloran PF, Merino Lopez M, Barreto Pereira A.

Am J Transplant. 2016 Mar;16(3):908-20. doi: 10.1111/ajt.13551. Epub 2016 Jan 6.

Supplemental Content

Support Center